In breast cancer biopsies, high LAT1 expression is associated with invasive breast cancer where LAT1 overexpression positively correlates with the expression of the estrogen receptor (ER) and the programmed death ligand-1 (PD-L1) (79). Here, ESR1 is linked to breast carcinoma.